Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald F Watts

Showing results (201-210 of 706) with videos related to

Pageof 71
Sort By:
Current Opinion in Lipidology|April 21, 2017
Beyond cascade screening: detection of familial hypercholesterolaemia at childhood immunization and other strategiesAndrew C Martin, Damon A Bell, Tom Brett, et al.
Annals of Clinical Biochemistry|March 20, 2014
A novel missense SMPD1 gene mutation, T460P, and clinical findings in a patient with Niemann-Pick disease type B presenting to a lipid disorders clinicYael Grasko, Amanda J Hooper, John R Burnett, et al.
European Heart Journal|February 25, 2016
Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217Marianne Benn, Gerald F Watts, Anne Tybjærg-Hansen, et al.
The Journal of Clinical Endocrinology and Metabolism|August 16, 2012
Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medicationMarianne Benn, Gerald F Watts, Anne Tybjaerg-Hansen, et al.
Pharmacological Research|March 6, 2025
Phytosterols and phytostanols in context: From physiology and pathophysiology to food supplementation and clinical practiceMassimiliano Ruscica, Wann Jia Loh, Cesare R Sirtori, et al.
Current Opinion in Endocrinology, Diabetes, and Obesity|October 30, 2023
Adherence to pharmacotherapy: sine qua non for reducing cumulative risk of premature coronary disease in familial hypercholesterolemiaJing Pang, Frank M Sanfilippo, Dick C Chan, et al.
Heart, Lung & Circulation|February 28, 2012
INTERIM guidelines for the diagnosis and management of familial hypercholesterolaemiaDavid R Sullivan, Ian Hamilton-Craig, Frank van Bockxmeer, et al.
Vascular Health and Risk Management|December 11, 2012
Mipomersen and other therapies for the treatment of severe familial hypercholesterolemiaDamon A Bell, Amanda J Hooper, Gerald F Watts, et al.
Atherosclerosis|March 9, 2007
Dyslipidaemia and cardiorenal disease: mechanisms, therapeutic opportunities and clinical trialsDoris T Chan, Ashley B Irish, Gursharan K Dogra, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 17, 2015
Insulin resistance and vascular dysfunction in chronic kidney disease: mechanisms and therapeutic interventionsDoris T Chan, Gerald F Watts, Ashley B Irish, et al.
Pageof 71

Showing results (201-210 of 706) with videos related to

Sort By:
Pageof 71
Current Opinion in Lipidology|April 21, 2017
Beyond cascade screening: detection of familial hypercholesterolaemia at childhood immunization and other strategiesAndrew C Martin, Damon A Bell, Tom Brett, et al.
Annals of Clinical Biochemistry|March 20, 2014
A novel missense SMPD1 gene mutation, T460P, and clinical findings in a patient with Niemann-Pick disease type B presenting to a lipid disorders clinicYael Grasko, Amanda J Hooper, John R Burnett, et al.
European Heart Journal|February 25, 2016
Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217Marianne Benn, Gerald F Watts, Anne Tybjærg-Hansen, et al.
The Journal of Clinical Endocrinology and Metabolism|August 16, 2012
Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medicationMarianne Benn, Gerald F Watts, Anne Tybjaerg-Hansen, et al.
Pharmacological Research|March 6, 2025
Phytosterols and phytostanols in context: From physiology and pathophysiology to food supplementation and clinical practiceMassimiliano Ruscica, Wann Jia Loh, Cesare R Sirtori, et al.
Current Opinion in Endocrinology, Diabetes, and Obesity|October 30, 2023
Adherence to pharmacotherapy: sine qua non for reducing cumulative risk of premature coronary disease in familial hypercholesterolemiaJing Pang, Frank M Sanfilippo, Dick C Chan, et al.
Heart, Lung & Circulation|February 28, 2012
INTERIM guidelines for the diagnosis and management of familial hypercholesterolaemiaDavid R Sullivan, Ian Hamilton-Craig, Frank van Bockxmeer, et al.
Vascular Health and Risk Management|December 11, 2012
Mipomersen and other therapies for the treatment of severe familial hypercholesterolemiaDamon A Bell, Amanda J Hooper, Gerald F Watts, et al.
Atherosclerosis|March 9, 2007
Dyslipidaemia and cardiorenal disease: mechanisms, therapeutic opportunities and clinical trialsDoris T Chan, Ashley B Irish, Gursharan K Dogra, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 17, 2015
Insulin resistance and vascular dysfunction in chronic kidney disease: mechanisms and therapeutic interventionsDoris T Chan, Gerald F Watts, Ashley B Irish, et al.
Pageof 71